Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 182
 
About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Advertise Login 
     

    Article Cited by others

ORIGINAL ARTICLE

Beneficial erythropoietic effects of recombinant human erythropoietin in very low-birth weight infants: A single-center randomized double-blinded placebo-controlled trial

Basiri Behnaz, Shokouhi Maryam, Pezeshki Nasrolah, Torabian Saadat

Year : 2015| Volume: 4| Issue : 2 | Page no: 87-90

   This article has been cited by
 
1 Early erythropoiesis-stimulating agents in preterm or low birth weight infants
Arne Ohlsson,Sanjay M Aher
Cochrane Database of Systematic Reviews. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants
Sanjay M Aher,Arne Ohlsson
Cochrane Database of Systematic Reviews. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants
Sanjay M Aher,Arne Ohlsson
Cochrane Database of Systematic Reviews. 2019;
[Pubmed]  [Google Scholar] [DOI]
4 Early erythropoiesis-stimulating agents in preterm or low birth weight infants
Arne Ohlsson,Sanjay M Aher
Cochrane Database of Systematic Reviews. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article